Standard BioTools Inc.LABNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+97.7%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+97.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
30.2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202546.75%
2024-128.77%
202334.08%
2022-72.26%
2021-32.18%
20201.55%
2019-7.63%
201817.47%
201720.26%
2016-45.93%